STOK — Stoke Therapeutics, Inc. | XLV Holdings | StockAdder

(STOK)

Stoke Therapeutics, Inc.

Live chart and latest STOK stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

STOK News

Baillie Gifford & Co. Purchases New Position in Stoke Therapeutics, Inc. $STOK

Apr 14, 2026 Investing.com

Allan Jonathan, Stoke Therapeutics general counsel, sells $313k in STOK stock

Mar 24, 2026 Stock Titan

Stoke Therapeutics (STOK) director receives 30,782-share stock option grant

Apr 7, 2026 Yahoo Finance

A Look at Stoke Therapeutics (STOK) Valuation After a 167% Year-to-Date Surge

Dec 2, 2025 simplywall.st

Is Stoke Therapeutics (STOK) Still Attractive After A 346% One Year Share Price Surge

Mar 4, 2026 GuruFocus

Wolfe Research Initiates Coverage on Stoke Therapeutics (STOK) w

Apr 8, 2026 Yahoo Finance

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Mar 17, 2026 Investing.com

Stoke Therapeutics stock falls after delayed Phase 3 readout timeline

Jan 12, 2026 Stock Titan

Stoke Therapeutics (STOK) CMO sells 1,838 shares in planned open-market trade

Apr 3, 2026 MarketBeat

Stoke Therapeutics, Inc. (NASDAQ:STOK) Receives Average Rating of "Moderate Buy" from Analysts

Apr 1, 2026 MarketBeat

Stoke Therapeutics (NASDAQ:STOK) Stock Price Expected to Rise, Needham & Company LLC Analyst Says

Mar 17, 2026 Yahoo Finance

Stoke Therapeutics (STOK): Exploring Valuation After a 2% Monthly Gain and 200% YTD Growth

Oct 21, 2025 Stock Titan

Stoke Therapeutics (STOK) director Kahn Clare submits initial Form 3 insider report

Apr 7, 2026 Investing.com

Leggett, Stoke Therapeutics CFO, sells $147k in STOK stock

Mar 19, 2026 Stock Titan

Clare Kahn joins Stoke Therapeutics (Nasdaq: STOK) board, receives option grant